SuPRA: Using Wearable Activity Trackers With a New Application to Improve Physical Activity in Knee Osteoarthritis

NCT02585323 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2025-10-06

Study results available
· View outcomes & findings →

Summary

Physical activity is an essential first-line treatment for patients with knee osteoarthritis (OA). However, only 13% of patients meet the activity recommendation of 150 minutes or more per week. The primary goal of this randomized controlled trial is to assess the efficacy of a Fitbit Flex (a wireless physical activity tracking device) paired with a new application, plus a brief education session and telephone counselling by a physiotherapist (PT), to improve physical activity and reduce sedentary time in patients with knee osteoarthritis.

Conditions

Interventions

BEHAVIORAL

Education session, Fitbit/FitViz, PT counselling

Participants will receive a brief education session, use a physical activity tracker Fitbit Flex with paired with a FitViz app, and remote counseling by a PT. Intervention will be received immediately.

BEHAVIORAL

Same intervention with a 3 month delay

The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 3 month delay.

Sponsors & Collaborators

  • Simon Fraser University

    collaborator OTHER
  • Arthritis Research Centre of Canada

    collaborator OTHER
  • Fraser Health

    collaborator OTHER
  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • Vancouver Coastal Health Research Institute

    collaborator OTHER
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Linda Li, PhD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2019-08-21
Completion
2019-08-26

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02585323 on ClinicalTrials.gov